JPWO2020123569A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020123569A5 JPWO2020123569A5 JP2021531688A JP2021531688A JPWO2020123569A5 JP WO2020123569 A5 JPWO2020123569 A5 JP WO2020123569A5 JP 2021531688 A JP2021531688 A JP 2021531688A JP 2021531688 A JP2021531688 A JP 2021531688A JP WO2020123569 A5 JPWO2020123569 A5 JP WO2020123569A5
- Authority
- JP
- Japan
- Prior art keywords
- adas
- composition
- cargo
- atp concentration
- parent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000894006 Bacteria Species 0.000 claims 13
- ZKHQWZAMYRWXGA-KQYNXXCUSA-N Adenosine triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-N 0.000 claims 11
- 210000004027 cells Anatomy 0.000 claims 11
- 229940039696 Lactobacillus Drugs 0.000 claims 6
- 241000186660 Lactobacillus Species 0.000 claims 6
- 241000192707 Synechococcus Species 0.000 claims 6
- 230000000694 effects Effects 0.000 claims 6
- 108090000623 proteins and genes Proteins 0.000 claims 6
- 102000004169 proteins and genes Human genes 0.000 claims 6
- 241000588698 Erwinia Species 0.000 claims 5
- 241000607768 Shigella Species 0.000 claims 5
- 206010040550 Shigella infection Diseases 0.000 claims 5
- 241000607598 Vibrio Species 0.000 claims 5
- 230000001580 bacterial Effects 0.000 claims 5
- 230000032823 cell division Effects 0.000 claims 5
- 229920001184 polypeptide Polymers 0.000 claims 5
- 241000186339 Thermoanaerobacter Species 0.000 claims 4
- 241000589291 Acinetobacter Species 0.000 claims 3
- 241000589158 Agrobacterium Species 0.000 claims 3
- 241000192542 Anabaena Species 0.000 claims 3
- 241000207208 Aquifex Species 0.000 claims 3
- 241000726110 Azoarcus Species 0.000 claims 3
- 241000589151 Azotobacter Species 0.000 claims 3
- 241000193830 Bacillus <bacterium> Species 0.000 claims 3
- 241000588807 Bordetella Species 0.000 claims 3
- 241000589173 Bradyrhizobium Species 0.000 claims 3
- 241000589562 Brucella Species 0.000 claims 3
- 241001453698 Buchnera <proteobacteria> Species 0.000 claims 3
- 241001453380 Burkholderia Species 0.000 claims 3
- 241000588881 Chromobacterium Species 0.000 claims 3
- 241000193403 Clostridium Species 0.000 claims 3
- 241000065719 Crocosphaera Species 0.000 claims 3
- 241001245615 Dechloromonas Species 0.000 claims 3
- 241000192093 Deinococcus Species 0.000 claims 3
- 241001509319 Desulfitobacterium Species 0.000 claims 3
- 241001560102 Desulfotalea Species 0.000 claims 3
- 241000588722 Escherichia Species 0.000 claims 3
- 241001468125 Exiguobacterium Species 0.000 claims 3
- 241000589601 Francisella Species 0.000 claims 3
- 241000605909 Fusobacterium Species 0.000 claims 3
- 241000626621 Geobacillus Species 0.000 claims 3
- 241001464794 Gloeobacter Species 0.000 claims 3
- 241000589236 Gluconobacter Species 0.000 claims 3
- 241000589989 Helicobacter Species 0.000 claims 3
- 241000589248 Legionella Species 0.000 claims 3
- 208000007764 Legionnaires' Disease Diseases 0.000 claims 3
- 241000721720 Magnetospirillum Species 0.000 claims 3
- 241000589345 Methylococcus Species 0.000 claims 3
- 241000178985 Moorella Species 0.000 claims 3
- 241000588653 Neisseria Species 0.000 claims 3
- 241000605122 Nitrosomonas Species 0.000 claims 3
- 241000192656 Nostoc Species 0.000 claims 3
- 241001072230 Oceanobacillus Species 0.000 claims 3
- 241000607568 Photobacterium Species 0.000 claims 3
- 241001148062 Photorhabdus Species 0.000 claims 3
- 241000512220 Polaromonas Species 0.000 claims 3
- 241000192138 Prochlorococcus Species 0.000 claims 3
- 241000589516 Pseudomonas Species 0.000 claims 3
- 241000588671 Psychrobacter Species 0.000 claims 3
- 241000232299 Ralstonia Species 0.000 claims 3
- 241001134722 Rubrivivax Species 0.000 claims 3
- 241000607142 Salmonella Species 0.000 claims 3
- 206010039447 Salmonellosis Diseases 0.000 claims 3
- 241000863430 Shewanella Species 0.000 claims 3
- 241001135312 Sinorhizobium Species 0.000 claims 3
- 241000207198 Symbiobacterium Species 0.000 claims 3
- 241000192584 Synechocystis Species 0.000 claims 3
- 241001313706 Thermosynechococcus Species 0.000 claims 3
- 241000204652 Thermotoga Species 0.000 claims 3
- 241000589596 Thermus Species 0.000 claims 3
- 241000605118 Thiobacillus Species 0.000 claims 3
- 241000192118 Trichodesmium Species 0.000 claims 3
- 241000498989 Wigglesworthia Species 0.000 claims 3
- 241000605941 Wolinella Species 0.000 claims 3
- 241000589634 Xanthomonas Species 0.000 claims 3
- 241000204366 Xylella Species 0.000 claims 3
- 241000607734 Yersinia <bacteria> Species 0.000 claims 3
- 108020004707 nucleic acids Proteins 0.000 claims 3
- 150000007523 nucleic acids Chemical class 0.000 claims 3
- 102000004190 Enzymes Human genes 0.000 claims 2
- 108090000790 Enzymes Proteins 0.000 claims 2
- 229940088597 Hormone Drugs 0.000 claims 2
- 102000004389 Ribonucleoproteins Human genes 0.000 claims 2
- 108010081734 Ribonucleoproteins Proteins 0.000 claims 2
- 150000001413 amino acids Chemical class 0.000 claims 2
- 150000001720 carbohydrates Chemical class 0.000 claims 2
- 238000004108 freeze drying Methods 0.000 claims 2
- 239000005556 hormone Substances 0.000 claims 2
- 239000002955 immunomodulating agent Substances 0.000 claims 2
- 230000002584 immunomodulator Effects 0.000 claims 2
- 229940121354 immunomodulators Drugs 0.000 claims 2
- 150000002632 lipids Chemical class 0.000 claims 2
- 108060004909 minC Proteins 0.000 claims 2
- 239000011146 organic particle Substances 0.000 claims 2
- 239000011242 organic-inorganic particle Substances 0.000 claims 2
- 150000003384 small molecules Chemical class 0.000 claims 2
- 229920000160 (ribonucleotides)n+m Polymers 0.000 claims 1
- 241000238631 Hexapoda Species 0.000 claims 1
- 241000970829 Mesorhizobium Species 0.000 claims 1
- 241000607479 Yersinia pestis Species 0.000 claims 1
- 210000004102 animal cell Anatomy 0.000 claims 1
- 230000000844 anti-bacterial Effects 0.000 claims 1
- 230000000843 anti-fungal Effects 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 238000002512 chemotherapy Methods 0.000 claims 1
- 229920003013 deoxyribonucleic acid Polymers 0.000 claims 1
- 230000001747 exhibiting Effects 0.000 claims 1
- 238000005755 formation reaction Methods 0.000 claims 1
- 239000003102 growth factor Substances 0.000 claims 1
- 238000009169 immunotherapy Methods 0.000 claims 1
- 230000000749 insecticidal Effects 0.000 claims 1
- 239000002917 insecticide Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
Claims (29)
(a)複数の高活性非染色体性動的活性システム(ADAS)を含む組成物を提供することであって、ADASが少なくとも1.25mMの初期ATP濃度を有し、ADASがカーゴを含み、及び組成物が生存細菌細胞を実質的に含まないこと;及び
(b)標的細胞をステップ(a)の前記組成物と接触させ、カーゴを標的細胞に送達すること
を含む、方法。 A method of delivering cargo to a target cell, comprising:
(a) providing a composition comprising a plurality of highly active achromosomal dynamic activity systems (ADAS), the ADAS having an initial ATP concentration of at least 1.25 mM, the ADAS comprising cargo; and (b) contacting a target cell with said composition of step (a) to deliver cargo to the target cell.
(a)複数の高活性非染色体性動的活性システム(ADAS)を含む組成物を提供することであって、ADASが少なくとも1.25mMの初期ATP濃度を有し、且つ組成物が生存細菌細胞を実質的に含まない、提供すること;及び
(b)動物を有効量のステップ(a)の組成物と接触させ、動物を処置すること
を含む、方法。 A method of treating an animal in need of treatment comprising:
(a) providing a composition comprising a plurality of highly active achromosomal dynamic activity systems (ADAS), wherein the ADAS have an initial ATP concentration of at least 1.25 mM and the composition comprises viable bacterial cells and (b) contacting the animal with an effective amount of the composition of step (a) to treat the animal.
(a)複数の高活性非染色体性動的活性システム(ADAS)を含む組成物を提供することであって、ADASが少なくとも1.25mMの初期ATP濃度を有し、且つ組成物が生存細菌細胞を実質的に含まない、提供すること;及び
(b)植物又はその有害生物を有効量のステップ(a)の組成物と接触させ、植物を処置すること
を含む、方法。 A method of treating a plant in need of treatment, comprising:
(a) providing a composition comprising a plurality of highly active achromosomal dynamic activity systems (ADAS), wherein the ADAS have an initial ATP concentration of at least 1.25 mM and the composition comprises viable bacterial cells and (b) a method comprising contacting the plant or pest thereof with an effective amount of the composition of step (a) to treat the plant.
(a)細胞分裂トポロジー特異性因子のレベル又は活性の低下を呈する複数の親細菌を作成、提供、又は取得することであって、前記低下が、minE、及びminCポリペプチド又はminDポリペプチドの少なくとも1つの発現の低下を含む、作製、提供、又は取得すること、
(b)ミニ細胞の形成を許容する条件に親細菌を曝露すること、及び
(c)ミニ細胞を親細菌から分離し、それにより生存細菌細胞を実質的に含まない、複数のADASを含む組成物を作製すること
を含む、方法。 1. A method for producing a composition comprising a plurality of highly active achromosomal dynamic activity systems (ADAS), the composition being substantially free of viable bacterial cells, the method comprising:
(a) producing, providing, or obtaining a plurality of parent bacteria exhibiting reduced levels or activities of cell division topology-specific factors, said reduced levels of at least minE and minC or minD polypeptides; making, providing, or obtaining, including reducing the expression of one;
(b) exposing the parent bacteria to conditions permissive for the formation of minicells; and (c) separating the minicells from the parent bacteria, thereby substantially free of viable bacterial cells. A method, including making an object.
ADASが、少なくとも1mMの初期ATP濃度を有し、
組成物が、生存細菌細胞を実質的に含まず、
ADASが、minEポリペプチド、及びminCポリペプチド又はminDポリペプチドの少なくとも1つの発現の低下を呈する親細菌に由来し、且つ
ADASのATP濃度が、37℃で12時間インキュベートした後に増加する、
組成物。 A composition comprising a plurality of highly active achromosomal dynamic activity systems (ADAS),
ADAS has an initial ATP concentration of at least 1 mM;
the composition is substantially free of viable bacterial cells;
The ADAS is derived from a parent bacterium that exhibits reduced expression of a minE polypeptide and at least one of a minC or minD polypeptide, and the ATP concentration of the ADAS is increased after 12 hours of incubation at 37°C.
Composition.
22. The composition of claim 21, wherein the parent bacterium has a deletion of the minCDE operon.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862777305P | 2018-12-10 | 2018-12-10 | |
US62/777,305 | 2018-12-10 | ||
PCT/US2019/065562 WO2020123569A1 (en) | 2018-12-10 | 2019-12-10 | Achromosomal dynamic active systems |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2022513709A JP2022513709A (en) | 2022-02-09 |
JPWO2020123569A5 true JPWO2020123569A5 (en) | 2022-12-19 |
Family
ID=71077548
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021531688A Pending JP2022513709A (en) | 2018-12-10 | 2019-12-10 | Non-chromosomal dynamic activity system |
Country Status (15)
Country | Link |
---|---|
US (1) | US20220031862A1 (en) |
EP (1) | EP3893856A4 (en) |
JP (1) | JP2022513709A (en) |
KR (1) | KR20210101260A (en) |
CN (1) | CN113498338A (en) |
AU (1) | AU2019397460A1 (en) |
BR (1) | BR112021011044A2 (en) |
CA (1) | CA3121520A1 (en) |
CL (2) | CL2021001466A1 (en) |
CO (1) | CO2021008980A2 (en) |
EA (1) | EA202191632A1 (en) |
IL (1) | IL283510A (en) |
MX (1) | MX2021006564A (en) |
SG (1) | SG11202105822WA (en) |
WO (1) | WO2020123569A1 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018201160A1 (en) | 2017-04-28 | 2018-11-01 | Agrospheres, Inc. | Compositions and methods for enzyme immobilization |
CA3056801A1 (en) | 2017-04-28 | 2018-11-01 | Agrospheres, Inc. | Compositions and methods for the encapsulation and scalable delivery of agrochemicals |
WO2019060903A1 (en) | 2017-09-25 | 2019-03-28 | Agrospheres, Inc. | Compositions and methods for scalable production and delivery of biologicals |
WO2021257788A1 (en) * | 2020-06-17 | 2021-12-23 | Flagship Pioneering Innovations Vi, Llc | Methods for manufacturing adas |
BR112022025633A2 (en) * | 2020-06-17 | 2023-03-07 | Flagship Pioneering Innovations Vi Llc | ADAS UNDERSTANDING BACTERIAL SECRETION SYSTEMS |
CN112342233B (en) * | 2020-11-10 | 2022-08-26 | 上海陶宇晟生物技术有限责任公司 | Polynucleotide for increasing c-di-AMP production when bacteria express DacA |
WO2023164454A2 (en) * | 2022-02-22 | 2023-08-31 | Board Of Regents For The Oklahoma Agricultural And Mechanical Colleges | Compositions and methods for improved rhizobium-mediated plant transformation |
WO2023250487A1 (en) | 2022-06-23 | 2023-12-28 | Flagship Pioneering Innovations Vi, Llc | Adas comprising type 1 pili |
CN115851800A (en) * | 2022-09-20 | 2023-03-28 | 天津大学 | Method for improving electronic transmission capacity of Shewanella |
WO2024107843A1 (en) | 2022-11-15 | 2024-05-23 | Flagship Pioneering Innovations Vi, Llc | Stabilized achromosomal dynamic active systems and uses thereof |
WO2024107853A1 (en) * | 2022-11-15 | 2024-05-23 | Flagship Pioneering Innovations Vi, Llc | Optimized achromosomal dynamic active systems and uses thereof |
WO2024137842A1 (en) * | 2022-12-20 | 2024-06-27 | University Of Kentucky Research Foundation | Bacterial type iv secretion systems, methods of use for in vivo dna delivery, and method of engineering |
WO2024158837A2 (en) | 2023-01-24 | 2024-08-02 | Flagship Pioneering Innovations Vii, Llc | Peptide in combination with fungicide compositions for fungal control and related methods |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030194798A1 (en) * | 2001-05-24 | 2003-10-16 | Surber Mark W. | Minicell compositions and methods |
EP1858920B1 (en) * | 2005-02-18 | 2016-02-03 | GlaxoSmithKline Biologicals SA | Proteins and nucleic acids from meningitis/sepsis-associated escherichia coli |
US9844598B2 (en) * | 2011-12-13 | 2017-12-19 | Engeneic Molecular Delivery Pty Ltd | Bacterially derived, intact minicells for delivery of therapeutic agents to brain tumors |
AU2014225717B2 (en) * | 2013-03-07 | 2019-01-17 | President And Fellows Of Harvard College | Compositions and methods for bacterial delivery of polypeptides |
CA3056801A1 (en) * | 2017-04-28 | 2018-11-01 | Agrospheres, Inc. | Compositions and methods for the encapsulation and scalable delivery of agrochemicals |
-
2019
- 2019-12-10 WO PCT/US2019/065562 patent/WO2020123569A1/en active Application Filing
- 2019-12-10 SG SG11202105822WA patent/SG11202105822WA/en unknown
- 2019-12-10 US US17/299,377 patent/US20220031862A1/en active Pending
- 2019-12-10 EP EP19896469.4A patent/EP3893856A4/en active Pending
- 2019-12-10 CN CN201980079718.5A patent/CN113498338A/en active Pending
- 2019-12-10 EA EA202191632A patent/EA202191632A1/en unknown
- 2019-12-10 MX MX2021006564A patent/MX2021006564A/en unknown
- 2019-12-10 BR BR112021011044-5A patent/BR112021011044A2/en unknown
- 2019-12-10 AU AU2019397460A patent/AU2019397460A1/en active Pending
- 2019-12-10 JP JP2021531688A patent/JP2022513709A/en active Pending
- 2019-12-10 CA CA3121520A patent/CA3121520A1/en active Pending
- 2019-12-10 KR KR1020217020753A patent/KR20210101260A/en unknown
-
2021
- 2021-05-27 IL IL283510A patent/IL283510A/en unknown
- 2021-06-03 CL CL2021001466A patent/CL2021001466A1/en unknown
- 2021-07-07 CO CONC2021/0008980A patent/CO2021008980A2/en unknown
-
2023
- 2023-05-30 CL CL2023001550A patent/CL2023001550A1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Quehenberger et al. | Sulfolobus–a potential key organism in future biotechnology | |
JPWO2020123569A5 (en) | ||
Ito et al. | Mrp antiporters have important roles in diverse bacteria and archaea | |
Vu et al. | Lanthanide-dependent regulation of methanol oxidation systems in Methylobacterium extorquens AM1 and their contribution to methanol growth | |
Chen et al. | Surfactin: a quorum-sensing signal molecule to relieve CCR in Bacillus amyloliquefaciens | |
Sanders et al. | Environmental stress responses in Lactococcus lactis | |
Lemos et al. | Physiologic effects of forced down-regulation of dnaK and groEL expression in Streptococcus mutans | |
Serrano et al. | H+‐PPases: yesterday, today and tomorrow | |
Zhang et al. | The ascorbate transporter of Escherichia coli | |
US20220031862A1 (en) | Achromosomal dynamic active systems | |
Shimada et al. | Classification and strength measurement of stationary-phase promoters by use of a newly developed promoter cloning vector | |
Duong et al. | Characterization of the tre locus and analysis of trehalose cryoprotection in Lactobacillus acidophilus NCFM | |
AU2015363113A1 (en) | Compositions and methods for efficient gene editing in E. coli using guide RNA/Cas endonuclease systems in combination with circular polynucleotide modification templates | |
Lecointe et al. | Involvement of an X family DNA polymerase in double‐stranded break repair in the radioresistant organism Deinococcus radiodurans | |
AU2021292539A1 (en) | ADAS comprising bacterial secretion systems | |
CN113166752A (en) | Lactic acid producing transformant of hydrogenophilus bacteria | |
Hoppert et al. | Principles of macromolecular organization and cell function in bacteria and archaea | |
EP4168025A1 (en) | Methods for manufacturing adas | |
Ciaramella et al. | Molecular biology of extremophiles | |
Argueta et al. | Identification of Nostoc punctiforme akinete‐expressed genes using differential display | |
Koo et al. | Robust Biocatalysts Displayed on Crystalline Protein‐Layered Cells for Efficient and Sustainable Hydration of Carbon Dioxide | |
US20150056168A1 (en) | Bacterial expression system | |
CN116064360A (en) | Method for improving freeze-drying survival rate of strain | |
CN105723219A (en) | Recombinant microorganisms and methods of use thereof | |
Ballal et al. | Differential expression of the two kdp operons in the nitrogen-fixing cyanobacterium Anabaena sp. strain L-31 |